Eco Animal Health Group PLC (LSE:EAH) Share Price

Company Profile

Business description
Eco Animal Health Group PLC is engaged in manufacturing and marketing animal health products. The company's product portfolio includes Aivlosin - macrolide antibiotic for the treatment of respiratory and enteric diseases in pigs and poultry; Ecomectin, Eco heart, Ecotraz, and Ecomintic for treatment and prevention of parasites in cattle, sheep, pigs, horses, and dogs; and Chlortetracycline and Oxytetracycline for treatment of bacterial infections in pigs, poultry and cattle. The company's geographical segments include Corporate/UK, China & Japan, North America, South & South East Asia, Latin America, Europe, and the Rest of the World. Maximum revenue for the company is generated from China and Japan.
Contact
100 High street
The Grange
Southgate
LondonN14 6BN
GBR
T: +44 2084478899
E: [email protected]
https://www.ecoanimalhealth.com
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 March 2026
Employees
219

Recommended

Despite a 40% share price rally this year, investors could still be underestimating Alibaba’s cloud growth prospects.

Chelsey Tam | 14 August 2025

A round up of notable stories and reactions as ASX earnings season gathers steam.

Joseph Taylor | 14 August 2025

Have shares surged too far?

Nathan Zaia | 14 August 2025

Index	Last price	Change	% Change
All Ordinaries	9,149.10	46.00	0.51%
CAC 40	7,870.34	65.37	0.84%
DAX 40	24,377.50	191.91	0.79%
Dow JONES (US)	44,851.22	71.05	-0.16%
FTSE 100	9,177.24	12.01	0.13%
HKSE	25,519.32	94.35	-0.37%
NASDAQ	21,703.20	9.94	-0.05%
Nikkei 225	42,649.26	625.41	-1.45%
NZX 50 Index	12,834.08	67.54	0.53%
S&P 500	6,462.81	3.77	-0.06%
S&P/ASX 200	8,873.80	46.70	0.53%
SSE Composite Index	3,666.44	17.02	-0.46%